These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12099389)

  • 1. Follow-up height after discontinuation of growth hormone treatment in children with intrauterine growth retardation.
    Darendeliler F; Bundak R; Eryilmaz SK; Günöz H; Baş F; Saka N
    J Pediatr Endocrinol Metab; 2002 Jun; 15(6):795-800. PubMed ID: 12099389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone in the treatment of short stature in young children with intrauterine growth retardation.
    Czernichow P; Fjellestad-Paulsen A
    Horm Res; 1998; 49 Suppl 2():23-7. PubMed ID: 9730668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with growth hormone in short children born with intrauterine growth retardation.
    Czernichow P
    Endocrine; 2001 Jun; 15(1):39-42. PubMed ID: 11572323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation.
    Fjellestad-Paulsen A; Czernichow P; Brauner R; Bost M; Colle M; Lebouc JY; Lecornu M; Leheup B; Limal JM; Raux MC; Toublanc JE; Rappaport R
    Acta Paediatr; 1998 May; 87(5):511-7. PubMed ID: 9641731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children.
    Coutant R; Carel JC; Letrait M; Bouvattier C; Chatelain P; Coste J; Chaussain JL
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1070-4. PubMed ID: 9543119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone treatment of short children born small for gestational age: reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years.
    de Zegher F; Butenandt O; Chatelain P; Albertsson-Wikland K; Jonsson B; Löfström A; Chaussain JL
    Acta Paediatr Suppl; 1997 Nov; 423():207-12. PubMed ID: 9401574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small for gestational age (SGA): endocrine and metabolic consequences and effects of growth hormone treatment.
    Hokken-Koelega AC; De Waal WJ; Sas TC; Van Pareren Y; Arends NJ
    J Pediatr Endocrinol Metab; 2004 Mar; 17 Suppl 3():463-9. PubMed ID: 15134308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment of children with short stature secondary to intra-uterine growth retardation: effect of 2 years' treatment and 2 years' follow-up.
    Rosilio M; Carel JC; Blazy D; Chaussain JL
    Horm Res; 1997; 48 Suppl 4():23-8. PubMed ID: 9350442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS.
    Ranke MB; Lindberg A;
    Horm Res Paediatr; 2010; 74(4):259-266. PubMed ID: 20431273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone treatment in growth hormone-sufficient and -insufficient children with intrauterine growth retardation/Russell-Silver syndrome.
    Azcona C; Albanese A; Bareille P; Stanhope R
    Horm Res; 1998; 50(1):22-7. PubMed ID: 9691209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
    Lindgren AC; Ritzén EM
    Acta Paediatr Suppl; 1999 Dec; 88(433):109-11. PubMed ID: 10626558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GH treatment induces sustained catch-up growth in children with intrauterine growth retardation: 7-year results.
    Albanese A; Stanhope R
    Horm Res; 1997; 48(4):173-7. PubMed ID: 9378463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of IGF-1 in children born small for gestational age and with growth retardation, treated by growth hormone adapted to IGF-1 levels after 1 year.
    Cabrol S; Perin L; Colle M; Coutant R; Jésuran-Perelroizen M; Le Bouc Y; Czernichow P
    Horm Res Paediatr; 2011; 76(6):419-27. PubMed ID: 22156543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.